Technology | PACS | January 06, 2017

Mirada Medical Highlights Molecular Imaging PACS Products at RSNA 2016

Latest version of XD:PACS helps integrate advanced nuclear imaging analysis into the enterprise

Mirada Medical, RSNA 2016, XD:PACS, molecular imaging, nuclear imaging

January 6, 2017 — Mirada Medical showcased its latest XD:PACS (picture archiving and communication system) range of molecular imaging products at the 2016 Radiological Society of North America (RSNA) annual meeting, Nov. 27-Dec. 1 in Chicago.

Mirada’s XD:PACS products are designed to empower radiology and nuclear medicine departments seeking to integrate advanced positron emission tomography (PET)/computed tomography (CT) reading, tumor tracking, single photon emission computed tomography (SPECT)/CT and nuclear medicine analysis into the enterprise. According to the company, XD:PACS products enable departments to dispense with the complexity and expense of having disparate legacy modality workstations and software packages.

The product range also includes the latest solutions for cardiology, neurology, radiation therapy and tumor board meetings. The software comprises flexible workflows and display protocols and results can always be saved for both editing and review on PACS.

For more information: www.mirada-medical.com

Related Content

Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”. We have been virtualizing various aspects of our lives for many years, but the circumstances of this one has moved almost all of our lives into the virtual realm.

Getty Images

Feature | Radiology Education | September 18, 2020 | By Jef Williams
Of all the buzzwords one would have guessed would dominate 2020, few expected it to be “virtual”.
Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer.

Indeterminate lesion on PET/CT classified by PET/MRI for 53-y-old man with lung cancer. Contrast-enhanced CT (A), PET (B), and fused 18F-FDG PET/CT (C) images are displayed in comparison with contrast-enhanced T1-weighted MRI (D), PET, and fused 18F-FDG PET/MRI (F) images. In CT (A), hyperdense, subcentimeter liver lesion (arrows) in segment VII is suggestive of transient hepatic attenuation difference or small hemangioma. As malignancy cannot be excluded, it needs further investigation. On PET/MRI, lesion is clearly classified as metastasis because of contrast enhancement and tracer uptake due to later acquisition time point. Follow-up CT confirmed diagnosis after 78 d. Images created by Ole Martin, University Dusseldorf, Medical Faculty and Benedikt Schaarschmidt, University Hospital Essen.

News | PET-MRI | September 18, 2020
September 18, 2020 — A single-center observational study of more than 1,000 oncological examinations has demonstrated
As the silos of data and diagnostic imaging PACS systems are being collapsed and secured, the modular enterprise imaging platform approach is gaining significance, offering systemness and security
Feature | Coronavirus (COVID-19) | September 18, 2020 | By Anjum M. Ahmed, M.D., MBBS, MBA, MIS
COVID-19 is now everywhere, and these are the lo
Cloud and cloud-native architecture is the future for computing solutions in EI applications

Getty Images

Feature | Enterprise Imaging | September 18, 2020 | By Henri “Rik” Premo
With over five years of presence in the rapidly expanding...
Claritas iRAD Platform

Claritas iRAD Platform

News | Information Technology | September 10, 2020
September 10, 2020 — With a mission to empo
Exa Gateway connects hospital radiology departments, radiology practices and teleradiologists through technology and services to enable cost-effective and efficient remote reading capabilities.

Exa Gateway connects hospital radiology departments, radiology practices and teleradiologists through technology and services to enable cost-effective and efficient remote reading capabilities.

News | Teleradiology | September 10, 2020
September 10, 2020 — As radi
Videos | Cardiac Imaging | August 12, 2020
Advanced visualization company...